Home Coronavirus COVID-19 Johnson & Johnson Covid-19 Vaccine: 66% Effective in Global Trial, but 85%... Johnson & Johnson Covid-19 Vaccine: 66% Effective in Global Trial, but 85% Against Severe Disease January 29, 2021 You are unauthorized to view this page. Username or E-mail Password Remember Me Forgot Password RELATED ARTICLESMORE FROM AUTHOR Moody’s: Trade Tariffs Would Disrupt US-Mexico Commerce Worth $740 Billion Sheinbaum NOT Planning to Deport US Citizens Mexico Received Over 4,000 Deportees Last Week Trump’s 25% Tariffs on Mexico Due Saturday Trump Declares ‘National Emergency’ at Mexican Border; Deploys 1,500 Troops
